• Most Popular
  • Most Shared

Roche sees human trials with RNAi drugs in 2 years

LONDON
Mon Jul 9, 2007 3:21am EDT

Stocks

   

LONDON (Reuters) - Roche Holding AG (ROG.VX) expects to start first tests in humans using RNA interference (RNAi) drugs within two years, the Swiss drugmaker's head of global pharma research said on Monday.

Lee Babiss told reporters in a conference call that the first products entering clinical trials from its new alliance with Alnylam Pharmaceuticals Inc. (ALNY.O) were likely to be in chronic obstructive pulmonary diseases (COPD), type 2 diabetes and liver metastasis in colorectal cancer.


More from Reuters

Photo

Copenhagen climate talks in trouble

COPENHAGEN (Reuters) - Prospects for a strong U.N. climate change deal grew more remote on Thursday at the climax of two years of talks, with developed and developing nations deadlocked on sharing cuts in greenhouse gases. | Video

» More Top News
Marine from Delta Company of 2nd Light Armored Reconnaissance Battalion patrols near the town of Khan Neshin in Rig district of Helmand province, southern Afghanistan September 10, 2009. REUTERS/Goran Tomasevic

A bloody fight looms

Marines on the frontlines of the Afghan surge in Helmand Province are ramping up for a battle that their commander says will be the "end of the line" for insurgents.  Full Article 

AFGHANISTAN
The tail section of the turboprop MQ-9 Predator B drone is seen on the tarmac at Fort Huachuca, Arizona, December 5, 2006.

Just don't say the D-word

In the high-testosterone world of military jets, the words "drone" and "unmanned aerial vehicle" don't fly. Now there's a new term in town.  Full Article 

AEROSPACE & DEFENSE SUMMIT